Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_001033855.3(DCLRE1C):c.95C>G (p.Ser32Cys)

CA376065642

2136852 (ClinVar)

Gene: DCLRE1C (HGNC:64421)

Condition: severe combined immunodeficiency due to DCLRE1C deficiency (MONDO:0011225)

Inheritance Mode: Autosomal recessive inheritance

UUID: 78a7041b-31ae-4b6c-9561-39870c271524

Approved on: 2024-01-23

Published on: 2024-01-23

HGVS expressions

NM_001033855.3:c.95C>G

NM_001033855.3(DCLRE1C):c.95C>G (p.Ser32Cys)

NC_000010.11:g.14953916G>C

CM000672.2:g.14953916G>C

NC_000010.10:g.14995915G>C

CM000672.1:g.14995915G>C

NC_000010.9:g.15035921G>C

NG_007276.1:g.5180C>G

ENST00000378278.7:c.95C>G

ENST00000357717.6:c.-110C>G

ENST00000378241.5:c.-478C>G

ENST00000378246.6:c.-195C>G

ENST00000378249.5:c.-143C>G

ENST00000378254.5:c.-397C>G

ENST00000378255.5:c.-719C>G

ENST00000378258.5:c.-351C>G

ENST00000378278.6:c.95C>G

ENST00000378289.8:c.95C>G

ENST00000396817.6:c.-673C>G

ENST00000418843.5:c.-434C>G

ENST00000456122.1:c.-602C>G

NM_001033855.2:c.95C>G

NM_001033857.2:c.-351C>G

NM_001033858.2:c.-673C>G

NM_001289076.1:c.-110C>G

NM_001289077.1:c.-397C>G

NM_001289078.1:c.-143C>G

NM_001289079.1:c.-719C>G

NM_022487.3:c.-195C>G

NR_110297.1:n.517C>G

NM_001350965.1:c.95C>G

NM_001350966.1:c.-143C>G

NM_001350967.1:c.-351C>G

NR_146960.1:n.517C>G

NR_146961.1:n.517C>G

NR_146962.1:n.517C>G

NM_001033857.3:c.-351C>G

NM_001033858.3:c.-673C>G

NM_001289076.2:c.-110C>G

NM_001289077.2:c.-397C>G

NM_001289078.2:c.-143C>G

NM_001289079.2:c.-719C>G

NM_001350965.2:c.95C>G

NM_001350966.2:c.-143C>G

NM_001350967.2:c.-351C>G

NM_022487.4:c.-195C>G

NR_110297.2:n.181C>G

NR_146961.2:n.181C>G

Likely Pathogenic

PM3_Supporting PP4 PM2_Supporting PS3_Moderate PM5_Supporting

BS2

Evidence Links 0

Expert Panel

Severe Combined Immunodeficiency Disease VCEP

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for DCLRE1C Version 1.0.0

Criteria Specification Approval History

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Severe Combined Immunodeficiency Disease VCEP

The c.95C>G (NM_001033855.3) variant in DCLRE1C is a missense variant predicted to cause substitution of Serine by Cysteine at amino acid 32 (p.Ser32Cys). The highest population minor allele frequency in gnomAD v.4 is 0.00002236 (1/44722 alleles) in Latino/Admixed American population, which is lower than the ClinGen SCID VCEP threshold (<0.00003266) for PM2_Supporting, meeting this criterion (PM2_Supporting). Another missense variant, c.95C>T; p.Ser32Phe, ClinVar Variation ID: 1438811, in the same codon, has been classified as likely pathogenic for SCID by the ClinGen SCID VCEP (PM5_Supporting). The variant was identified in two patients in the literature (PubMed IDs 25917813, 15242402, and PMID: 35886058. The patient reported in Rosina E et al. presents: Diagnostic criteria for SCID 0.5 pts + SCID gene panel or exome/genome sequencing conducted 0.5pts + T-B-NK+ lymphocyte subset profile 0.5 pts, total is 1.5 points, PP4_Supporting. This same patient is homozygous for the variant: 0.5 pts, PM3_Supporting (PMID: 35886058). Activity levels in % of WT activity = Recombination: Mean (SD): 0 (0.4) and DNA repair (36h after IR): Mean (SD): 6.56 (8.73). Both values are lower than our established threshold for abnormal results (defined as <25% of wild-type activity). Thus, PS3 is Met at a moderate level (PMID: 25917813). In summary, this variant is classified as Likely Pathogenic for autosomal recessive severe combined immunodeficiency due to DCLRE1C deficiency based on ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP (specification version 1.0): PM2_Supporting, PM5_Supporting, PP4_Supporting, PM3_Supporting, and PS3_Moderate.

PM3_Supporting

The patient reported in Rosina E et al. is homozygous for this variants. 0.5 pts, PM3_Supporting (PMID: 35886058).

PP4

The variant was identified in two patients in the literature (PubMed IDs 25917813, 15242402, and PMID: 35886058. The patient reported in Rosina E et al. presents: Diagnostic criteria for SCID 0.5 pts + SCID gene panel or exome/genome sequencing conducted 0.5pts + T-B-NK+ lymphocyte subset profile 0.5 pts, total is 1.5 points, PP4_Supporting. .

PM2_Supporting

The highest population minor allele frequency in gnomAD v4 is 0.00002236 (1/44722 alleles) in Latino/Admixed American population, which is lower than the ClinGen SCID VCEP threshold (<0.00003266) for PM2_Supporting, meeting this criterion (PM2_Supporting).

PS3_Moderate

Activity levels in % of WT activity = Recombination: Mean (SD): 0 (0.4) and DNA repair (36h after IR): Mean (SD): 6.56 (8.73). Both values are lower than our established threshold for abnormal results (defined as <25% of wild-type activity). Thus, PS3 is Met at a moderate level (PMID: 25917813).

PM5_Supporting

Another missense variant, c.95C>T; p.Ser32Phe, ClinVar Variation ID: 1438811, in the same codon, has been classified as likely pathogenic for SCID by the ClinGen SCID VCEP (PM5_Supporting).

BS2

No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.